non – nucleoside reverse transcriptase inhibitors:
Influence of non-nucleoside reverse transcriptase inhibitors (efavirenz and nevirapine) on the pharmacodynamic activity of gliclazide in animal models
... Gliclazide is a widely used drug for the treatment of type 2 diabetes. Efavirenz and nevirapine are widely used non-nucleoside reverse transcriptase inhibitors for the treatment of HIV ...
8
2D and 3D QSAR of Benzimidazole Analogues as Novel HIV-1 Non Nucleoside Reverse Transcriptase Inhibitors
... Context: Acquired Immuno Deficiency Syndrome (AIDS) is a viral disease caused by Human Immunodeficiency Virus. There is an urgent need to identify newer NNRTIs active against these mutant strains Literature survey has ...
7
Molecular modeling studies of HIV-1 non-nucleoside reverse transcriptase inhibitors using 3D-QSAR, virtual screening and docking simulations
... (Received 4 September, revised 15 October, accepted 15 November 2018) Abstract: Acquired immunodeficiency syndrome (AIDS) is a significant human health threat around the world and therefore, the study of anti-HIV drug ...
14
Comparative Study of Various Non-Nucleoside Reverse Transcriptase Inhibitors on Different Reverse Transcriptase Enzyme
... of nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs/ NTRIs) and non-nucleoside reverse tran- scriptase inhibitors (NNRTIs), protease inhibitors ...
7
AZOLES AS NON NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS (NNRTIs): MINI REVIEW
... Two NNRTIs (nevirapine and delavirdine) have been formally licensed for clinical use and several others are (or have been) in preclinical and: or clinical development [tivirapine (TIBO R-86183), loviride (a-APA R89439), ...
6
AN INSIGHT TO STRUCTURAL ANALYSIS OF COUMARINS AS NON NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS
... O O O O OH In order to define ligand-receptor interactions, docking of all the low energy conformations within a range of 5 kcal/mol/Aº from the lowest energy conformation of each molecule, into the cavity of 3HVT, 1IKW, ...
18
Increase in transmitted resistance to non nucleoside reverse transcriptase inhibitors among newly diagnosed HIV 1 infections in Europe
... The NRTI and NNRTI drug classes showed the same significant predictors for resistance in the univariate analyses as was shown for the overall TDRM, although the square root CD4 cell coun[r] ...
12
Inhibitory activity of 9 phenylcyclohepta[d]pyrimidinedione derivatives against different strains of HIV 1 as non nucleoside reverse transcriptase inhibitors
... Also similar to NVP, BmPCP inhibits HIV-1 infection by targeting the post entry of the HIV-1 replication cycle by time-of-additional assay. Furthermore, in vitro HIV-1 reverse transcriptase activity assays ...
6
Weight gain among treatment-naïve persons with HIV starting integrase inhibitors compared to non-nucleoside reverse transcriptase inhibitors or protease inhibitors in a large observational cohort in the United States and Canada.
... Methods: Adult, treatment-na €ıve PWH in NA-ACCORD initiating integrase strand transfer inhibitor (INSTI), protease inhibitor (PI) or non-nucleoside reverse-transcriptase inhibitor ...
9
Synthesis, biological evaluation and docking study of 2 amino 4,6 diarylpyrimidines as novel non nucleoside HIV 1reverse transcriptase inhibitors
... (DAPY’s)as Non-nucleoside reverse transcriptase inhibitors (NNRTIs) were designed, synthesized and evaluated for in vitro reverse transcriptase (RT) inhibition ...on ...
9
Benzophenone Derivatives: a Novel Scaffold as Non-Nucleoside HIV-1 Reverse Transcriptase Inhibitors
... HIV inhibitors, the SARs of BPs were provided in this manuscript, which were overviewed as below: (1) the carbonyl between the A- and B-ring was necessary for maintaining the pharmacodynamics conformation of this ...
9
Dolutegravir Plus Two Nucleoside Reverse Transcriptase Inhibitors versus Efavirenz Plus Two Nucleoside Reverse Transcriptase Inhibitors As Initial Antiretroviral Therapy for People with HIV: A Systematic Review.
... the non-nucleoside reverse transcriptase inhibitor (NNRTI) efavirenz (EFV) as the preferred regimen in non-pregnant and non-breast- feeding adults [ 14 ...integrase ...
14
Impact of Y181C and/or H221Y mutation patterns of HIV 1 reverse transcriptase on phenotypic resistance to available non nucleoside and nucleoside inhibitors in China
... Our data in this study are based on the recombined subtype B’ viruses and pNL4-3 wild-type. Viral evolution pathways toward drug resistance may proceed through distinct steps and at different rates among different HIV-1 ...
7
Role of Ligand Reorganization and Conformational Restraints on the Binding Free Energies of DAPY Non Nucleoside Inhibitors to HIV Reverse Transcriptase
... ABSTRACT The results of computer simulations of the binding of etravirine (TMC125) and rilpivirine (TMC278) to HIV reverse transcriptase are reported. It is confirmed that consistent binding free energy ...
16
Involvement of Novel Human Immunodeficiency Virus Type 1 Reverse Transcriptase Mutations in the Regulation of Resistance to Nucleoside Inhibitors
... It should be noted that all patients analyzed in this study carried the HIV-1 subtype B. Further studies should also in- vestigate the prevalence and the role of the novel mutations in other non-B subtypes. In ...
13
Bench to bedside review: Severe lactic acidosis in HIV patients treated with nucleoside analogue reverse transcriptase inhibitors
... 35. Modica-Napolitano JS: AZT causes tissue specific inhibition of mitochondrial bioenergetic function. Biochem Biophys Res Commun 1993, 194:170-177. 36. Chariot P, Monnet I, Mouchet M, Rohr M, Lefaucheur JP, Dubreuil- ...
7
Synthesis and docking analysis of new 2 chloro 3 ((2,2 dimethylhydrazono) methyl)quinoline derivatives as non nucleoside human HIV 1 reverse transcriptase inhibitors
... as non-nucleoside Human HIV-1 Reverse Transcriptase ...as non-nucleoside Human HIV-1 Reverse Transcriptase Inhibitors via docking ...
6
Selective killing of human immunodeficiency virus infected cells by non nucleoside reverse transcriptase inhibitor induced activation of HIV protease
... identified inhibitors showing higher potency with respect to PR activation than previously described for NNRTIs, with the most potent compounds resulting in ~2-fold increase of the Gag processing signal at 250 ...
14
The Genetic Basis of HIV-1 Resistance to Reverse Transcriptase and Protease Inhibitors
... the reverse transcriptase (RT) and protease enzymes, the molecular targets of antiretroviral ...available nucleoside RT inhibitors, non- nucleoside RT inhibitors, and ...
18
R5 Variants of Human Immunodeficiency Virus Type 1 Preferentially Infect CD62L− CD4+ T Cells and Are Potentially Resistant to Nucleoside Reverse Transcriptase Inhibitors
... to reverse transcriptase ...the nucleoside reverse tran- scriptase inhibitors (NRTI) zidovudine and lamivudine to stop HIV-1 replication were 20 times greater in activated T cells than ...
12